1-3 of 3
Lingyun Xiong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug Response

Available to Purchase
Ping Zhang, Isaac Kitchen-Smith, Lingyun Xiong, Giovanni Stracquadanio, Katherine Brown, Philipp H. Richter, Marsha D. Wallace, Elisabeth Bond, Natasha Sahgal, Samantha Moore, Svanhild Nornes, Sarah De Val, Mirvat Surakhy, David Sims, Xuting Wang, Douglas A. Bell, Jorge Zeron-Medina, Yanyan Jiang, Anderson J. Ryan, Joanna L. Selfe, Janet Shipley, Siddhartha Kar, Paul D. Pharoah, Chey Loveday, Rick Jansen, Lukasz F. Grochola, Claire Palles, Andrew Protheroe, Val Millar, Daniel V. Ebner, Meghana Pagadala, Sarah P. Blagden, Timothy S. Maughan, Enric Domingo, Ian Tomlinson, Clare Turnbull, Hannah Carter, Gareth L. Bond
Journal: Cancer Research
Cancer Res (2021) 81 (7): 1667–1680.
https://doi.org/10.1158/0008-5472.CAN-20-0177
Published: 01 April 2021
View articletitled, Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug Response
Open the PDF for Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug Response in another window
Includes: Supplementary data
Journal Articles

Abstract #846: The PHSCNGGK-dendrimer inhibits growth of human breast and prostate cancer cells through inducing apoptosis

Free
Zhao-Zhu Zeng, Paul Danielsky, Evan Staszewski, Hongren Yao, Kevin Fay, Donna Veine, Lingyun Xiong, Korrene Rockwood, Sonja Markwart, Donna Livant
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 846.
Published: 01 May 2009
View articletitled, Abstract #846: The PHSCNGGK-dendrimer inhibits growth of human breast and prostate cancer cells through inducing apoptosis
Journal Articles

Abstract #3090: The PHSCNGGK-dendrimer is more potent than the PHSCN peptide as an inhibitor of invasion and extravasation by human breast and prostate cancer cells

Free
Hongren Yao, Kevin Fay, Evan Staszewski, Zhao-Zhu Zeng, Donna Veine, Paul Danielsky, Lingyun Xiong, Donna Livant
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 3090.
Published: 01 May 2009
View articletitled, Abstract #3090: The PHSCNGGK-dendrimer is more potent than the PHSCN peptide as an inhibitor of invasion and extravasation by human breast and prostate cancer cells